Skip to main content
Clinical Trials/JPRN-UMIN000004460
JPRN-UMIN000004460
Completed
Phase 2

eoadjuvant chemotherapy and radiotherapy for operable breast cancer - Neo CR

Osaka Medical Center for Cancer and Cardiovascular Diseases0 sites35 target enrollmentOctober 27, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Osaka Medical Center for Cancer and Cardiovascular Diseases
Enrollment
35
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 27, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Osaka Medical Center for Cancer and Cardiovascular Diseases

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) past history of any invasive malignancy within the previous 5 years 2\) past history of breast cancer or synchronous bilateral breast cancer 3\) past history of radiotherapy for ipsilateral breast 4\) Suspicious of allergy for radiotherapy 5\) Suspicious of allergy for paclitaxel, 5FU, epirubicin or cyclophosphamide 7\) Patients during uncontrollable diabetes or psychologic disorder 8\) Patients who have grade3\-4 neuropathy 9\) Pregnant or breast\-feeding 10\) Any reason the physician believes that the patient is not appropriate to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials